In response to the recent spike of COVID-19 cases, Clorox Malaysia has outlined support for relief efforts by contributing to two of the main public health facilities for the treatment of COVID-19 cases, Hospital Sungai Buloh and Hospital Universiti Malaya; as well as to a non-governmental organization, MERCY Malaysia. The brand contributed a total of RM80,000 in products that will be used to limit the spread of the virus in everyday life, and in the workplace at the three organizations.
Cleaning and disinfection are critical in reducing the spread of COVID-19, especially in medical facilities where the risk of infection spreading from the infected to the healthy is high. Disinfecting hard surfaces is carried out frequently for this purpose, and the amount of product required daily is high.
Clorox Bleach and Clorox All Purpose Cleaner Spray were contributed for the thorough cleaning and disinfection of the facilities, while Clorox Expert Disinfecting Wipes are for the daily individual use of frontliners, patients and visitors at these facilities.
According to Paulo M. Lao, Sales & Marketing Director of Clorox Southeast Asia, “we are proud that our products can help to effectively clean and disinfect their facilities, and can be used by frontliners, patients and visitors for a safer environment because Clorox believes that clean matters.”
He added that third-party testing confirms the efficacy of several of Clorox’s top disinfecting products against SARS-CoV-2 strains¹ including the Alpha (UK) and Beta (South African) variants of concern (VOC). These results are in line with a US Environmental Protection Agency announcement that genetic changes to the virus do not impact the efficacy of disinfectants and all disinfectants approved to kill SARS-CoV-2, will kill new strains of the virus.
Disclaimer²: Clorox cleaning and disinfectant products are not suitable for consumption or injection under any circumstances. It is advisable to always read the label for instructions on proper usage.
¹ The three strains include SARS-Related Coronavirus 2 (SARS-CoV-2), Isolate hCoV19/England/204820464/2020 (BEI Resources # NR-54000), SARS-Related Coronavirus 2 (SARS-CoV-2), Isolate hCoV19/South Africa/KRISP-EC-K005321/2020 (BEI Resources # NR-54008) and SARS-Related Coronavirus 2 (SARS-CoV-2), Isolate USA/CA_CDC_5574/2020 (BEI Resources # NR-54011). https://investors.thecloroxcompany.com/investors/news-and-events/press-releases/press-release-details/2021/Testing-Confirms-Efficacy-of-Clorox-Products-Against-Variants-of-SARS-CoV-2-COVID-19-on-Surfaces/default.aspx
² Clorox statement on proper use of disinfection products. https://www.thecloroxcompany.com/covid-19/learn-about-covid-19/clorox-statement-on-the-proper-use-of-disinfecting-products/